Focus on SSE: Southeast Asia Series III
The Shanghai Stock Exchange (SSE) held the "Focus on SSE: Southeast Asia Series III" on July 11, 2025. Approximately 40 overseas participants from Southeast investment institutions and intermediaries joined the event online.
In the market updates session, the SSE provided a comprehensive introduction to the SSE STAR Market development and the recently released "1+6" measures.
In the corporate access session, two SSE-listed Pharmaceutical companies—Hengrui Pharmaceuticals and Biokin Pharmaceutical—engaged with Southeast Asian investors to highlight the investment value of the companies.
If you would like to join our subsequent events or subscribe to SSE News updates, please contact:
